Advisors Preferred’s Transmedics TMDX Stock Holding History

Advisors Preferred’s Portfolio TMDX Stock Details TMDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-4,748	Closed	-$618K	–	294
2025 Q2	$618K	Buy	+4,748	New	+$521K	0.1%	113

Other funds holding TMDX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Advisors Preferred's TMDX Position: Q3 2025 in Review

Advisors Preferred sold out of Transmedics (TMDX) in Q3 2025, closing a stake of 4,748 shares — an estimated $618K sold.

Advisors Preferred first reported a position in TMDX in Q2 2025 and held it in 1 quarter. The position peaked at $618K in Q2 2025. 388 funds tracked by Wall St. Rank hold TMDX as of Q3 2025.

Advisors Preferred reported no remaining Transmedics position as of Q3 2025 after selling out during the quarter.
Advisors Preferred sold 4,748 Transmedics shares in Q3 2025, an estimated $618K.
Advisors Preferred first reported a position in Transmedics in Q2 2025 and held it in 1 quarter.
Advisors Preferred's Transmedics position peaked at $618K in Q2 2025.
388 funds tracked by Wall St. Rank held Transmedics as of Q3 2025.

Based on Advisors Preferred's 13F filing for Q3 2025, filed 10 Nov 2025.